Powered by OpenAIRE graph
Found an issue? Give us feedback
image/svg+xml Jakob Voss, based on art designer at PLoS, modified by Wikipedia users Nina and Beao Closed Access logo, derived from PLoS Open Access logo. This version with transparent background. http://commons.wikimedia.org/wiki/File:Closed_Access_logo_transparent.svg Jakob Voss, based on art designer at PLoS, modified by Wikipedia users Nina and Beao HAL-Pasteurarrow_drop_down
image/svg+xml Jakob Voss, based on art designer at PLoS, modified by Wikipedia users Nina and Beao Closed Access logo, derived from PLoS Open Access logo. This version with transparent background. http://commons.wikimedia.org/wiki/File:Closed_Access_logo_transparent.svg Jakob Voss, based on art designer at PLoS, modified by Wikipedia users Nina and Beao
HAL-Pasteur
Article . 2017
Data sources: HAL-Pasteur
image/svg+xml Jakob Voss, based on art designer at PLoS, modified by Wikipedia users Nina and Beao Closed Access logo, derived from PLoS Open Access logo. This version with transparent background. http://commons.wikimedia.org/wiki/File:Closed_Access_logo_transparent.svg Jakob Voss, based on art designer at PLoS, modified by Wikipedia users Nina and Beao
HAL Descartes
Article . 2017
Data sources: HAL Descartes
image/svg+xml Jakob Voss, based on art designer at PLoS, modified by Wikipedia users Nina and Beao Closed Access logo, derived from PLoS Open Access logo. This version with transparent background. http://commons.wikimedia.org/wiki/File:Closed_Access_logo_transparent.svg Jakob Voss, based on art designer at PLoS, modified by Wikipedia users Nina and Beao
HAL-ENS-LYON
Article . 2017
Data sources: HAL-ENS-LYON
image/svg+xml Jakob Voss, based on art designer at PLoS, modified by Wikipedia users Nina and Beao Closed Access logo, derived from PLoS Open Access logo. This version with transparent background. http://commons.wikimedia.org/wiki/File:Closed_Access_logo_transparent.svg Jakob Voss, based on art designer at PLoS, modified by Wikipedia users Nina and Beao
HAL INRAE
Article . 2017
Data sources: HAL INRAE
versions View all 5 versions
addClaim

[Opportunistic infections and sarcoidosis].

Authors: Jamilloux, Yvan; Bernard, C.; Lortholary, O.; Kerever, S.; Lelievre, L.; Gerfaud-Valentin, M.; Broussolle, C.; +2 Authors

[Opportunistic infections and sarcoidosis].

Abstract

Les infections opportunistes (IO) sont rares en cas de sarcoïdose (1 à 10 %) et surviennent le plus souvent au cours de sarcoïdose connue ou, plus rarement, la révèlent. Les IO les plus fréquentes sont par ordre décroissant : l’aspergillose pulmonaire, la cryptococcose et les infections mycobactériennes. La corticothérapie systémique représente le facteur de risque le plus fréquent d’IO au cours de la sarcoïdose mais les immunosuppresseurs et les anti-TNFα peuvent aussi être en cause. Le plus souvent, la présentation clinique, le traitement et le devenir des patients ne diffèrent pas des autres conditions favorisant la survenue d’une IO. Néanmoins, certaines présentations atypiques d’IO peuvent mimer une exacerbation de la sarcoïdose et la confusion risque de conduire le clinicien à une intensification de l’immunosuppression, entraînant l’aggravation de l’IO. Le recueil minutieux des antécédents ainsi que la connaissance des indices permettant de différencier une IO d’une exacerbation de la sarcoïdose sont donc des facteurs clés dans la prise en charge de ces patients.

Opportunistic infections (OI) are uncommon in sarcoidosis (1 to 10%) and mostly occur in patients with previously diagnosed disease or can rarely be the presenting manifestation. The most common OIs are, in descending order: aspergillosis, cryptococcosis, and mycobacterial infections. Treatment with corticosteroids is the most frequent risk factor for OI occurrence during sarcoidosis but immunosuppressive drugs and therapy with anti-TNFalpha are also risk factors. Overall, clinical presentation, treatment, and outcome are identical to that occur in other conditions complicated with the occurrence of OIs. However, some atypical presentations of OIs can mimic sarcoidosis exacerbation and misdiagnosis may lead clinicians to increase immunosuppression, causing worsening of the OI. The meticulous collection of patient's history along with factors differentiating OI from sarcoidosis exacerbation is key factor to optimally manage these patients

Country
France
Keywords

Risk, therapy, Mycobacterium Infections, Patients, Sarcoidosis, Cryptococcosis, Opportunistic Infections, Immunocompromised Host, Rare Diseases, [SDV.CAN] Life Sciences [q-bio]/Cancer, Mycoses, Risk Factors, Virus Diseases, Medicine, Aspergillosis, Humans, history, France, Infection, Immunosuppression

  • BIP!
    Impact byBIP!
    selected citations
    These citations are derived from selected sources.
    This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).
    3
    popularity
    This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network.
    Average
    influence
    This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).
    Average
    impulse
    This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network.
    Average
Powered by OpenAIRE graph
Found an issue? Give us feedback
selected citations
These citations are derived from selected sources.
This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).
BIP!Citations provided by BIP!
popularity
This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network.
BIP!Popularity provided by BIP!
influence
This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).
BIP!Influence provided by BIP!
impulse
This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network.
BIP!Impulse provided by BIP!
3
Average
Average
Average
Related to Research communities
Cancer Research
Upload OA version
Are you the author of this publication? Upload your Open Access version to Zenodo!
It’s fast and easy, just two clicks!